J&J 3Q09 3Q Revenues: $15.1 billion (-5%) 3Q Earnings: $3.3 billion (+1%) YTD Revenues: $45.3 billion (-7%) YTD Earnings: $10.0 billion (-2%) Comments: Worldwide pharmaceutical revenues dropped 14% to $5.2 billion in 3Q09, with currency fluctuation accounting for 2% of that. U.S. pharma revenues dropped 19% to $2.9 billion. For the YTD, worldwide pharma revenues dropped 13% to $16.5 billion (4% from currency), with U.S. drug revenues falling 15% to $9.7 billion. During the qua...